共 77 条
- [1] Homesley HD(1998)Single-agent therapy for nonmetastatic and low-risk gestational trophoblastic disease J Reprod Med 43 69-74
- [2] Foulmann K(2006)What is the best protocol of single-agent methotrexate chemotherapy in nonmetastatic or low-risk metastatic gestational trophoblastic tumors? A review of the evidence Gynecol Oncol 102 103-110
- [3] Guastalla JP(1989)The role of low dose methotrexate and folinic acid in gestational trophoblastic tumors (GTT) Br J Obstet Gynaecol 96 795-802
- [4] Caminet N(2001)Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia Gynecol Oncol 82 367-370
- [5] Trillet-Lenoir V(1982)Treatment of nonmetastatic gestational trophoblastic disease: results of methotrexate alone versus methotrexate–folinic acid Am J Obstet Gynecol 144 88-323
- [6] Raudrant D(1985)Methotrexate with citrovorum factor in gestational trophoblastic disease Am J Obstet Gynecol 152 59-320
- [7] Golfier F(1976)Methotrexate with citrovorum factor rescue for nonmetastatic gestational trophoblastic neoplasms Obstet Gynecol 48 321-118
- [8] Bagshawe KD(1980)Medium-dose methotrexate folinic acid regimen in the chemotherapy of gestational trophoblastic disease Med J Aust 1 317-8
- [9] Dent J(1986)Ten years’ experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease Gynecol Oncol 23 111-2112
- [10] Newlands ES(1998)Comparison of chemotherapies with methotrexate, VP-16and actinomycin-D in low risk gestational trophoblastic disease. Remission rate and drug toxicities Gynecol Obstet Invest 46 5-1844